CompletedNCT02870283
Treatment Options and Quality of Life During Mixed Mood Episodes in Bipolarity
About this title
Read the official source — NCT02870283Medication studyAges 18–65
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMay 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 107
- Sponsor
- Federal University of Rio Grande do Sul
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02870283
- Official title
Show the full official title
Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Mood Disorders Through Resources Available in Brazilian Public Health
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Federal University of Rio Grande do Sul, a university.
Did this study involve medication?
Yes. The study involved medication, including lithium, Valproic Acid and Carbamazepine.
Who was this study for?
Listed age limits: 18 years to 65 years.
